Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune ...

Chemotherapy kills cancer cells, but it also leaves behind something troubling: damaged cells that stop dividing yet refuse to die. These senescent cells, sometimes called “zombie” cells, linger in ...

Please provide your email address to receive an email when new articles are posted on . Tumor infiltration into major blood vessels may be a key driver of cancer death. Clinical trials will evaluate ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Heart disease and cancer are the leading causes of death in the ...

Researchers at MD Anderson have identified RNase H2 as a key survival mechanism in triple-negative breast cancer, helping ...

Liposuction and plastic surgery aren’t often mentioned in the same breath as cancer. But they are the inspiration for a new approach to treating cancer that uses engineered fat cells to deprive tumors ...